The effect of Triheptanoin in adults with McArdle Disease (Glycogen Storage Disease Type V)
Phase of Trial: Phase II
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Triheptanoin (Primary)
- Indications Glycogen storage disease type V
- Focus Therapeutic Use
- 31 Aug 2017 Planned End Date changed from 1 Jul 2017 to 1 Jan 2019.
- 31 Aug 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Sep 2018.
- 03 Mar 2015 New trial record